Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-03 Option Award |
2025-02-14 4:23 pm |
N/A 2035-02-03 |
ArriVent BioPharma Inc. | AVBP | Kastenmayer James Paul General Counsel |
102,000 | $0 | 102,000 (Direct) |
View |
Ownership |
2024-01-25 8:38 pm |
N/A N/A |
ArriVent Biopharma Inc. | AVBP | Kastenmayer James Paul General Counsel |
0 | $0 | 106,004 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-24 6:24 pm |
N/A 2033-02-22 |
Aeglea BioTherapeutics Inc. | AGLE | Kastenmayer James Paul General Counsel |
500,000 | $0 | 500,000 (Direct) |
View |
| 2022-08-23 Option Award |
2022-08-25 7:39 pm |
N/A 2032-08-22 |
Aeglea BioTherapeutics Inc. | AGLE | Kastenmayer James Paul Interim CEO & General Counsel |
130,000 | $0 | 130,000 (Direct) |
View |
Ownership |
2022-08-25 7:37 pm |
N/A N/A |
Aeglea BioTherapeutics Inc. | AGLE | Kastenmayer James Paul Interim CEO & General Counsel |
0 | $0 | 219,000 (Direct) |
View |